C20ORF111 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.239600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.775000E-01
Normal-vs-Stage2
5.960800E-01
Normal-vs-Stage3
3.416600E-01
Normal-vs-Stage4
6.638200E-01
Stage1-vs-Stage2
7.599000E-03
Stage1-vs-Stage3
9.909600E-01
Stage1-vs-Stage4
7.208400E-02
Stage2-vs-Stage3
3.288400E-01
Stage2-vs-Stage4
9.832000E-01
Stage3-vs-Stage4
3.334000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.330000E-01
Normal-vs-AfricanAmerican
6.185600E-01
Normal-vs-Asian
6.546800E-01
Caucasian-vs-AfricanAmerican
9.314400E-01
Caucasian-vs-Asian
9.040400E-01
AfricanAmerican-vs-Asian
9.964200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.625600E-01
Normal-vs-Female
3.553200E-01
Male-vs-Female
1.913550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.228000E-01
Normal-vs-Age(41-60Yrs)
9.701400E-01
Normal-vs-Age(61-80Yrs)
3.306400E-01
Normal-vs-Age(81-100Yrs)
5.276200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.870410E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.250600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.403600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.104200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.090800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.100200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.979200E-01
Normal-vs-Daily Drinker
8.313600E-01
Normal-vs-Weekly Drinker
2.214600E-01
Normal-vs-Occasional Drinker
7.099800E-01
Normal-vs-Social Drinker
4.291400E-01
Non Drinker-vs-Daily Drinker
1.224990E-01
Non Drinker-vs-Weekly Drinker
8.337800E-01
Non Drinker-vs-Occasional Drinker
7.657000E-03
Non Drinker-vs-Social Drinker
5.773000E-01
Daily Drinker-vs-Weekly Drinker
1.761160E-01
Daily Drinker-vs-Occasional Drinker
2.477200E-01
Daily Drinker-vs-Social Drinker
3.959600E-01
Weekly Drinker-vs-Occasional Drinker
2.043700E-02
Weekly Drinker-vs-Social Drinker
7.026000E-01
Occasional Drinker-vs-Social Drinker
6.325900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.649200E-01
Normal-vs-Grade 2
8.395600E-01
Normal-vs-Grade 3
5.586200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.062600E-03
Grade 1-vs-Grade 3
5.819900E-03
Grade 1-vs-Grade 4
9.649200E-01
Grade 2-vs-Grade 3
6.294400E-01
Grade 2-vs-Grade 4
8.395600E-01
Grade 3-vs-Grade 4
5.586200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.657800E-01
Normal-vs-NonDiabetic
5.967000E-01
Diabetic-vs-NonDiabetic
4.222000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.084400E-01
Normal-vs-NoPancreatitis
5.284600E-01
Pancreatitis-vs-NoPancreatitis
1.443770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.419800E-01
Normal-vs-N1
5.579800E-01
N0-vs-N1
6.515600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.935800E-01
Normal-vs-TP53-NonMutant
1.154200E-01
TP53-Mutant-vs-TP53-NonMutant
9.93880000521585E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
